SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001790340-24-000060
Filing Date
2024-06-13
Accepted
2024-06-13 16:09:51
Documents
13
Period of Report
2024-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K imrx-20240612.htm   iXBRL 8-K 29363
  Complete submission text file 0001790340-24-000060.txt   160709

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20240612.xsd EX-101.SCH 1926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20240612_lab.xml EX-101.LAB 23705
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20240612_pre.xml EX-101.PRE 13601
16 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20240612_htm.xml XML 2922
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 241041308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)